DJIA 16,380.41 263.17 1.63%
NASDAQ 4,258.44 41.05 0.97%
S&P 500 1,886.76 24.00 1.29%
market minute promo

AASTROM BIOSCIENCES, INC. (NASDAQ: ASTM)

2.79 0.09 (3.33%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ASTM $2.79 3.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.71
Previous Close $2.70
Daily Range $2.71 - $2.80
52-Week Range $2.55 - $7.00
Market Cap $22.3M
P/E Ratio -0.80
Dividend (Yield) $0.00 (0.0%)
Volume 80,548
Average Daily Volume 310,265
Current FY EPS -$2.60

Sector

Healthcare

Industry

Drugs

AASTROM BIOSCIENCES, INC. (ASTM) Description

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology. Website: http://www.aastrom.com/

News & Commentary Rss Feed

Aastrom Biosciences Finds a CEO

Dan Orlando stops being interim CEO, as Dominick Colangelo arrives to take charge.

Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics

Aastrom Biosciences Announces Plans To Change Name To Vericel Corporation And Move Headquarters To C

Aastrom Biosciences Announces Plans To Change Name To Vericel Corporation And Move Headquarters To Cambridge, Massachusetts

Stocks Hitting 52-Week Lows

Morning Market Losers

Morning Market Losers

Morning Market Movers

Second Quarter Results Confirm Why We Like Aastrom

Aastrom Biosciences' (ASTM) CEO Dominick Colangelo on Q2 2014 Results - Earnings Call Transcript

Aastrom Biosciences (ASTM) Q2 2014 Results - Earnings Call Webcast

Earnings Scheduled For August 13, 2014

See More ASTM News...

ASTM's Top Competitors

ASTM $2.79 (3.33%)
Current stock: ASTM
AMGN $133.69 (2.48%)
Current stock: AMGN
GILD $100.75 (3.99%)
Current stock: GILD
BIIB $306.71 (1.31%)
Current stock: BIIB